Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64851 - 64875 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	CCL22	6367	downregulated	resveratrol results in decreased expression of CCL22 mRNA	16q21	A23893
Resveratrol	Investigational	CCL26	10344	upregulated	resveratrol results in increased expression of CCL26 mRNA	7q11.23	A23852
Resveratrol	Investigational	CCL3	6348	downregulated	resveratrol results in decreased expression of CCL3 mRNA	17q12	A23893
Resveratrol	Investigational	CCNA1	8900	upregulated	resveratrol results in increased expression of CCNA1 mRNA	13q13.3	A20482
Resveratrol	Investigational	CCNA2	890	upregulated	resveratrol metabolite results in increased expression of CCNA2 mRNA	4q27	A20106
Resveratrol	Investigational	CCNA2	890	downregulated	resveratrol results in decreased expression of CCNA2 mRNA	4q27	A23857 A23858 A22121
Resveratrol	Investigational	CCNB1	891	downregulated	resveratrol results in decreased expression of CCNB1 mRNA	5q13.2	A22121
Resveratrol	Investigational	CCNB2	9133	downregulated	resveratrol results in decreased expression of CCNB2 mRNA	15q22.2	A23857
Resveratrol	Investigational	CCNB2	9133	upregulated	resveratrol results in increased expression of CCNB2 mRNA	15q22.2	A21103
Resveratrol	Investigational	CCND1	595	downregulated	resveratrol analog results in decreased expression of CCND1 mRNA	11q13.3	A20265
Resveratrol	Investigational	CCND1	595	upregulated	resveratrol metabolite results in increased expression of CCND1 mRNA	11q13.3	A20106
Resveratrol	Investigational	CCND1	595	downregulated	resveratrol results in decreased expression of CCND1 mRNA	11q13.3	A23894 A23895 A23873 A23863 A23882 A23883 A23871
Resveratrol	Investigational	CCND1	595	upregulated	resveratrol results in increased expression of CCND1 mRNA	11q13.3	A22733 A21177 A23863
Resveratrol	Investigational	CCNE2	9134	downregulated	resveratrol results in decreased expression of CCNE2 mRNA	8q22.1	A23857
Resveratrol	Investigational	CCNE2	9134	upregulated	resveratrol results in increased expression of CCNE2 mRNA	8q22.1	A21103
Resveratrol	Investigational	CCR2	729230	downregulated	resveratrol results in decreased expression of CCR2 mRNA	3p21.31	A23896
Resveratrol	Investigational	CD36	948	upregulated	resveratrol results in increased expression of CD36 mRNA	7q21.11	A23843
Resveratrol	Investigational	CD38	952	upregulated	resveratrol results in increased expression of CD38 mRNA	4p15.32	A23858 A23852
Resveratrol	Investigational	CDC123	8872	downregulated	resveratrol results in decreased expression of CDC123 mRNA	10p14-p13	A22498
Resveratrol	Investigational	CDC27	996	downregulated	resveratrol results in decreased expression of CDC27 mRNA	17q21.32	A23857 A23858
Resveratrol	Investigational	CDC6	990	downregulated	resveratrol results in decreased expression of CDC6 mRNA	17q21.2	A23857
Resveratrol	Investigational	CDCA8	55143	upregulated	resveratrol results in increased expression of CDCA8 mRNA	1p34.3	A21103
Resveratrol	Investigational	CDH1	999	upregulated	resveratrol results in increased expression of CDH1 mRNA	16q22.1	A21627 A23897 A23898 A23870
Resveratrol	Investigational	CDH2	1000	downregulated	resveratrol results in decreased expression of CDH2 mRNA	18q12.1	A23897 A23898
Resveratrol	Investigational	CDH23	64072	upregulated	resveratrol results in increased expression of CDH23 mRNA	10q22.1	A23852

Displaying entries 64851 - 64875 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability